powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1295199404
Karen Axten
M.D.
Medical Oncology
Boston,
MA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.
QUALITY · MIPS · 2024
Final MIPS score
88.4
Quality
79.9
Cost
82.2
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.56%
Group
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
CCN 120014
Hospital
CCN 120022
Hospital
CCN 120026
Hospital
CCN 123300
Hospital
CCN 380047
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
787
Beneficiaries
—
Total drug cost
$2.5M
Distinct drugs
15
Brand share
23.4%
Top prescribed drugs
Letrozole
362 claims
Abemaciclib
64 claims
Tamoxifen Citrate
64 claims
Alendronate Sodium
58 claims
Palbociclib
40 claims
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
163
Unique beneficiaries
—
Total services
359
Distinct HCPCS
4
Medicare payment
$36K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 257 Medical Oncology providers in MA — above median (cohort median 290).
